Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ra Pharmaceuticals Inc (RARX)

Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,271,555
  • Shares Outstanding, K 47,329
  • Annual Sales, $ 3,000 K
  • Annual Income, $ -102,690 K
  • 60-Month Beta 1.04
  • Price/Sales 757.42
  • Price/Cash Flow N/A
  • Price/Book 8.63
Trade RARX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.99
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.62
  • Number of Estimates 2
  • High Estimate -0.61
  • Low Estimate -0.63
  • Prior Year -0.45
  • Growth Rate Est. (year over year) -37.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.30 +19.09%
on 03/18/20
48.02 -0.05%
on 03/31/20
+1.24 (+2.64%)
since 02/28/20
3-Month
40.30 +19.09%
on 03/18/20
48.02 -0.05%
on 03/31/20
+1.06 (+2.27%)
since 12/31/19
52-Week
19.64 +144.37%
on 06/12/19
48.02 -0.05%
on 03/31/20
+27.20 (+130.86%)
since 04/01/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Ra Pharmaceuticals, Inc. is a biopharmaceutical company. It involved in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Ra Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 48.02
1st Resistance Point 48.01
Last Price 48.00
1st Support Level 47.98
2nd Support Level 47.97
3rd Support Level N/A

See More

52-Week High 48.02
Last Price 48.00
Fibonacci 61.8% 37.18
Fibonacci 50% 33.83
Fibonacci 38.2% 30.48
52-Week Low 19.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar